[1]
“Effect of glabridinon on insulin resistance, C-reactive protein and endothelial function in young women with polycystic ovary syndrome”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 681–687, Aug. 2015, doi: 10.3329/bjp.v10i3.23648.